APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY
https://doi.org/10.20996/1819-6446-2006-2-3-56-64
Abstract
Results of randomized clinical trials on the usage of calcium antagonists (CA) in order to prevent perioperative complications during aortocoronary bypass procedure and operations on heart valves are analyzed. CA reduced the risk of perioperative myocardial infarctions and episodes of reversible myocardial ischemia. After angioplasty of coronary arteries CA (particularly amlodipine) show positive effects on restenosis incidence and reduce about 3 times a number of repeated angioplasty and aortocoronary bypass operations. The use of CA was accompanied by more often need in heart electro stimulation without any subclass differences. It is also registered that nimodipine can strengthen intraoperative blood loss. It is concluded, that CA have significant evident base that allows recommending them to patients undertaken by cardiological surgery.
References
1. Литература
2. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2001.
3. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multi-vessel coronary disease. JAMA 1997;277:715-21.
4. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
5. Sarabu MR, McClung JA, Fass A, Reed GE. Early postoperative spasm in left internal mammary artery bypass grafts. Ann Thorac Surg 1987;44:199-200.
6. Talajic M, Papadatos D, Villemaire C, Nayebpour M, Nattel S. Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias: importance of use-dependent calcium channel-blocking properties. Circulation 1990;81:334-42.
7. Stanley TO, Mackensen GB, Grocott HP, et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94:290-5.
8. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA 1996;276:300-6.
9. Fisher M, Grotta J. New uses for calcium channel blockers: therapeutic implications. Drugs 1993;46:961-75.
10. Weightman WM, Gibbs NM, Sheminant MR, Whitford EG, Ma-hon BD, Newman MA. Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival. Anesth Analg 1999;88:286-91.
11. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995,92:1326-31.
12. Slogoff S, Keats AS. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia? Anesthesiology 1988;68:676-80.
13. Chung F, Houston PL, Cheng D, et al. Calcium channel blockade does not offer adequate protection from perioperative myocardial ischemia. Anesthesiology 1988;69:343-7.
14. Wijeysundera DN, Beattie WS, Rao V et al. Calcium antagonists reduce cardiovascular complications after cardiac surgery. JACC 2003: 41:1496-05.
15. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports on meta-analyses of randomised controlled trials: the QUO ROM statement. Lancet 1999;354:1896-900.
16. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
17. Shapira OM, Xu A, Vita JA, et al. Nitroglycerin is superior to diltiazem as a coronary bypass conduit vasodilator. J Thorac Cardiovase Surg 1999;117:906-ll.
18. Amano J, Suzuki A, Sunamori M, Tofukuji M. Effect of calcium antagonist diltiazem on renal function in open heart surgery. Chest1995;107:1260-5.
19. Apostolidou IA, Despotis GJ Hogue CW Jr., et al. Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting. Ann Thorac Surg 1999;67:417-22.
20. Babin-Ebell J, Keith PR, Elert O. Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. Eur J Cardiothorac Surg 1996;10:412-6.
21. Bertolissi M, Antonucci F, De Monte A, Padovani R, Giordano F.Effects on renal function of a continuous infusion of nifedipine during cardiopulmonary bypass. J Cardiothorac Vase Anesth 1996;10:238-42.
22. Colson P, Medioni P, Saussine M, et al. Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery. J Cardiothorac Vase Anesth 1992;6:424-8.
23. Combes P, Durand M. Comparison of nicardipine and sodium nitroprusside in the treatment of hypertension after coronary bypass surgery. Acta Anaesthesiol Belg 1992;43:113-9.
24. David D, Dubois C, Loria Y. Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery. J Cardiothorac Vase Anesth 1991;5:357-61.
25. Davison R, Hartz R, Kaplan K, Parker M, Feiereisel P, Michaelis L.Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial. Ann Thorac Surg 1985;39:336-9.
26. Donegani E, Costa P, De Paulis R, et al. Myocardial protection by perioperative diltiazem drip: a clinical evaluation. Thorac Cardiovasc Surg 1986;34:168-71.
27. Donmez A, Ergun F, Kayhan Z, Tasdelen A, Dogan S. Verapamil and nimodipine do not improve renal function during cardiopulmonary bypass. Acta Anaesthesiol Ital 1998;49:173-7.
28. Dupuis JY , Nathan HJ, Laganiere S. Intravenous nifedipine for prevention of myocardial ischaemia after coronary revascularization. CanJ Anaesth 1992;39:1012-22.
29. Ferraris VA, Ferraris SP, Gilliam H, Berry W. Verapamil prophylaxis for postoperative atrial dysrhythmias: a prospective, randomized, double-blind study using drug level monitoring. Ann Thorac Surg 1987;43:530-3.
30. Hannes W, Fasol R, Zajonc H, et al. Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting. Eur J Cardiothorac Surg 1993;7:239-45.
31. Hannes W, Seitelberger R, Christoph M, et al. Effect of perioperative diltiazem on myocardial ischaemia and function in patients receiving mammary artery grafts. Eur Heart J 1995;16:87-93.
32. Hicks GL Jr ., Salley RK, DeWeese JA. Calcium channel blockers: an intraoperative and postoperative trial in women. Ann Thorac Surg 1984;37:319-23.
33. Hirnle T, Stachurski A, Negrusz-Kawecka M, Halawa B, Bross T. Myocardial protection during coronary artery by-pass surgery with nitroglycerin or diltiazem. Kardiol Pol 2000;52:277- 84.
34. Keilich M, Kulinna C, Seitelberger R, Fasol R. Postoperative follow-up of coronary artery bypass patients receiving calcium antagonist diltiazem. Int J Angiol 1997;6:8-12.
35. Knothe C, Boldt J, Zickmann B, et al. Cardiac protection in heart surgery interventions by preventive drug administration before extracorporeal circulation: studies with troponin T as a parameter for perioperative myocardial damage. Herz 1993; 18:379-86.
36. Koolen JJ, van Wezel HB, Visser С A, et al. Nicardipine for preservation of myocardial metabolism and function in patients undergoing coronary artery surgery. Ancsthcsiology 1989;71:508-18.
37. Lassnigg A, Wutte M, Grubhofer G, et al. Diltiazem versus nitroglycerin for myocardial protection following coronary artery bypass grafting as assessed by dobutamine stress echocardiography. Wien Klin Wochenschr 2001;113:439-45.
38. Leslie J, Brister N, Levy JH, et al. Treatment of postoperative hypertension after coronary artery bypass surgery: double-blind comparison of intravenous isradipine and sodium nitroprus-side. Circulation 1994;90 Suppl 11:11256-61.
39. Lischke V, Probst S, Behne M, Dietrich HA. Prevention of myocardial ischemia: study following aortocoronary bypass operation with the calcium antagonist diltiazem. Anaesthesist 1995;44:92-100.
40. Malhotra R, Mishra M, Kler TS, Kohli UM, Mehta Y, Trehan N. Cardioprotective effects of diltiazem infusion in the perioperative period. Eur J Cardiothorac Surg 1997;12:420-7.
41. Nathan HJ, Laganiere S, Dube L, et al. Intravenous nifedipine to treat hypertension after coronary artery revascularization surgery: a comparison with sodium nitroprusside. Anesth Analg 1992;74:809-17.
42. Petry A, Wulf H, Blomer U, Wawersik J. Nifedipine versus nitroglycerin in aortocoronary bypass surgery: the effect on hemodynamics, kidney function and homologous blood requirement. Anaesthesist1992;41:39-46.
43. Ruegg PC, David D, Loria Y. Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside. Eur J Anaesthesiol 1992;9:293-305.
44. Seitelberger R, Hannes W, Gleichauf M, et al. Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting. J Thorac Cardiovasc Surg 1994;107:811-21.
45. Seitelberger R, Zwolfer W, Huber S, et al. Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronarj bypass grafting. Circulation 199l;83:460-8.
46. Seitelberger R, Zwolfer W, Binder TM, et al. Infusion of nifedipine after coronary artery bypass grafting decreases the incidence of early postoperative myocardial ischemia. Ann Thorac Surg 1990;49:61-7.
47. Shapira OM, Alkon JD, Macron DS, et al. Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm. Ann Thorac Sufg 2000:70:883-8.
48. Smith ЕЕ, Shore DF, Monro JL, Ross JK. Oral verapamil tails to prevent supraventricular tachycardia following coronary artery surgery. Int J Cardiol 1985;9:37-44.
49. van Wezel HB, Koolep JJ, Visser С A, et ai. The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension. J Cardiothorac Anesth 1989;3:700-6.
50. van Wezel HB, Koolen JJ, Visser CA, et al. Antihypertensive and antiischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting. Am J Cardiol 1989;64:22H-7H.
51. van Wezel HB, Bovill JG, Schuller J, Gielen J, Hoeneveld Mil. Comparison of nitroglycerine, verapamil and nifedipine in the management of arterial pressure during coronary artery surgery. Br J Anaesth 1986;58:267-73.
52. Williams DB, Misbach GA, Kruse AP, Ivey TD. Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial revascularization. J Thoracic Cardiovasc Surg 1985;90:592-6.
53. Zanardo G, Michielon P, Rosi P, et al. Effects of a continuous diltiazem infusion on renal function during cardiac surgery. J Cardiothorac Vase Anesth 1993;7:711-6.
54. Legault C, Furbcrg CD, Wagenknecht LE, et al. Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial. Stroke 1996;27:593-8.
55. Tschirkov A, Mishev B, Natschev G, Petkov R, Alexandro V, Jurukova Z. Perioperative myocardial protection with the calcium antagonist diltiazem. Eur J Cardiothorac Surg 1992;6:225- 35.
56. Fang W, Mao L. Pretreatment with nicardipine against myocardial damage in hypothermic extracorporeal circulation. Acta Acad Med Shanghai 1995;22:359-62.
57. Forsman M, Olsnes ВТ , Semb G, Steen PA. Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery. Br J Anaesth 1990;65:514-20
58. Schoneberger A, Raschka C, Reifart N, Hoffmann S, Satter P. Acomparative study of verapamil and propafenone in the prophylaxis of atrial fibrillation after cardiac surgery. Herz Kreislauf 1992;24:94-7.
59. HillegassW.B., Ohman E.M., Leimberger J.D., Califf R.M. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. Am. J. Cardiol. 1994; 73(12): 835-9.
60. Jorgensen B., Simonsen S., Endersen K., et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine RESstenosis Study (CAPARES). J.Am.Coll.Cardiol. 2000; 35:592-9.
61. Марцевич С.Ю., Кутишенко Н.П., Дмитриева Н.А. и др. Российский кардиологический журнал; 2004;4:53-57.
62. Маркова Л.И., Радзевич А.Э., Моргун Г.Д. Российский кардиологический журнал; 2005;4:63-67.
Review
For citations:
Nedogoda S.V. APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY. Rational Pharmacotherapy in Cardiology. 2006;2(3):56-64. (In Russ.) https://doi.org/10.20996/1819-6446-2006-2-3-56-64
Views:
995
Email this article 